Medpace Holdings Inc.(MEDP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MEDP Medpace Holdings Inc.

交易中 09-14 12:25:58 EDT

594.85

+7.33

+1.25%

最高600.89	最低589.44	成交量7.40万
今开595.99	昨收587.52	日振幅1.95%
总市值166.03亿	流通市值133.60亿	总股本2,791万
成交额4,391万	换手率0.33%	流通股本2,246万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MEDP","market":"US","secType":"STK","nameCN":"Medpace Holdings Inc.","latestPrice":594.85,"timestamp":1789403156101,"preClose":587.52,"halted":0,"volume":74020,"delay":0,"changeRate":0.012476171023965211,"floatShares":22458758,"shares":27910600,"eps":17.057537,"marketStatus":"交易中","change":7.33,"latestTime":"09-14 12:25:58 EDT","open":595.99,"high":600.885,"low":589.435,"amount":43906613.646,"amplitude":0.019489,"askPrice":594.69,"askSize":2,"bidPrice":594.13,"bidSize":40,"shortable":3,"etf":0,"ttmEps":17.057537,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1789416000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1470888000000,"exchange":"NASDAQ","adjPreClose":587.52,"preHourTrading":{"tag":"盘前","latestPrice":595.76,"preClose":587.52,"latestTime":"09:29 EDT","volume":127,"amount":74979.0728,"timestamp":1789392599983,"change":8.24,"changeRate":0.014025,"amplitude":0.016851},"postHourTrading":{"tag":"盘后","latestPrice":588.2,"preClose":587.52,"latestTime":"19:30 EDT","volume":2220,"amount":1304607.35,"timestamp":1789169408538,"change":0.68,"changeRate":0.001157,"amplitude":0.001157},"volumeRatio":0.918185,"impliedVol":0.335,"impliedVolPercentile":0.1873},"requestUrl":"/m/hq/s/MEDP","defaultTab":"news","newsList":[{"id":"1116533325","title":"Innventure宣布董事会领导层变动，旨在增强董事会独立性并加速CEO交接进程","url":"https://stock-news.laohu8.com/highlight/detail?id=1116533325","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116533325?lang=zh_cn&edition=full","pubTime":"2026-08-31 20:04","pubTimestamp":1788177870,"startTime":"0","endTime":"0","summary":"Innventure宣布了董事会领导层的一系列调整，此举旨在进一步提升董事会的独立性，同时加快首席执行官（CEO）的交接进程。该公告反映了公司对治理结构优化的持续关注，并显示出其正着手为高层管理层的平稳过渡铺平道路。通过这些变革，Innventure期望强化其监督职能，并确保公司战略方向的连续性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLMR","IE00B66KJ199.SGD","BK4107","LU2065169927.USD","BK4121","LU2065170008.USD","MAGN","LU2065171311.SGD","ARLO","BK4585","LU2211815571.USD","SG9999004303.SGD","SGXZ23171101.USD","IE00B7SZL793.SGD","IE00B19Z4B17.USD","IE0031619046.USD","MEDP","BK4588","INV","BK4135","LU2065171402.SGD","BK4157","BK4199"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126937658","title":"异动解读｜Medpace Holdings盘中上涨22.51%，Q2业绩全面超预期叠加全年指引上调","url":"https://stock-news.laohu8.com/highlight/detail?id=1126937658","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126937658?lang=zh_cn&edition=full","pubTime":"2026-07-23 21:30","pubTimestamp":1784813431,"startTime":"0","endTime":"0","summary":"7月23日，Medpace Holdings盘中上涨22.51%，报646.99美元/股，成交额509.69万美元。消息面上，公司公布第二季度财报，各项核心指标全面超越市场预期，叠加全年指引上调，双重利好推动股价大幅走高。Medpace是全球领先的临床合同研究组织，专注于为生物技术、制药和医疗器械行业提供I至IV期全流程临床开发服务，在肿瘤学、代谢疾病等领域具有突出优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184590885","title":"异动解读｜Medpace Holdings盘前上涨18.34%，Q2业绩全面超预期并上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1184590885","media":"行情直击","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184590885?lang=zh_cn&edition=full","pubTime":"2026-07-23 19:30","pubTimestamp":1784806231,"startTime":"0","endTime":"0","summary":"7月23日，Medpace Holdings盘前上涨18.34%，报620.04美元/股。消息面上，公司公布第二季度财报，各项核心指标全面超越市场预期，叠加全年指引上调，双重利好推动股价大幅走高。Medpace是全球领先的临床合同研究组织，专注于为生物技术、制药和医疗器械行业提供I至IV期全流程临床开发服务，在肿瘤学、代谢疾病等领域具有突出优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Medpace Q2业绩全面超预期并上调全年指引","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157578637","title":"异动解读 | Medpace夜盘大涨15.54%，Q2业绩全面超预期并上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1157578637","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157578637?lang=zh_cn&edition=full","pubTime":"2026-07-23 09:49","pubTimestamp":1784771373,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc.  今日夜盘股价大幅上涨15.54%，引起了市场的广泛关注。消息面上，公司公布了强劲的第二季度财务业绩，各项核心指标全面超越市场预期。具体来看，第二季度每股收益为4.25美元，超出分析师预期约7%；营收达到7.073亿美元，同样高于市场预期。Medpace是全球领先的临床合同研究组织，专注于为生物技术、制药和医疗器械行业提供全流程临床开发服务。此次业绩超预期与指引上调的双重利好，是推动其夜盘股价大涨的主要原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178712848","title":"异动解读｜Medpace Holdings夜盘上涨15.54%，Q2业绩全面超预期且上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1178712848","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178712848?lang=zh_cn&edition=full","pubTime":"2026-07-23 09:48","pubTimestamp":1784771311,"startTime":"0","endTime":"0","summary":"7月23日，Medpace Holdings夜盘上涨15.54%，报610.21美元/股。消息面上，公司公布第二季度财报，各项核心指标全面超越市场预期，叠加全年指引上调，双重利好推动股价大幅走高。全年指引方面，公司预计营收28.1亿至28.9亿美元，高于市场预期的27.7亿美元；预计全年EPS为17.25至17.95美元，亦超市场预期的16.97美元。Medpace是全球领先的临床合同研究组织，专注于为生物技术、制药和医疗器械行业提供I至IV期全流程临床开发服务，在肿瘤学、代谢疾病等领域具有突出优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184242515","title":"异动解读｜Medpace Holdings盘后上涨19.2%，Q2业绩全面超预期且上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1184242515","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184242515?lang=zh_cn&edition=full","pubTime":"2026-07-23 05:58","pubTimestamp":1784757514,"startTime":"0","endTime":"0","summary":"7月23日，Medpace Holdings盘后上涨19.2%，报629.5美元/股，成交额3012.56万美元。消息面上，公司公布第二季度财报，各项核心指标全面超越市场预期。业绩增长与指引上调双重利好推动股价盘后大幅走高。Medpace是全球领先的临床合同研究组织，专注于为生物技术、制药和医疗器械行业提供I至IV期全流程临床开发服务，在肿瘤学、代谢疾病等领域具有突出优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121289845","title":"异动解读 | Medpace第二季度业绩超预期，盘后股价大涨15.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=1121289845","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121289845?lang=zh_cn&edition=full","pubTime":"2026-07-23 04:35","pubTimestamp":1784752555,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc. (MEDP) 今日盘后股价大幅上涨15.69%，引起了市场的广泛关注。消息面上，公司公布了强劲的第二季度财务业绩。数据显示，Medpace该季度营收达到7.073亿美元，显著超越了此前分析师普遍预期的6.876亿美元。同时，公司实现净利润1.214亿美元，展现出强劲的盈利增长势头。这份超预期的财报是推动股价在盘后交易时段大涨的主要原因。业绩的超预期表现增强了市场对公司未来增长潜力的信心，从而吸引了大量买盘，推动股价显著走高。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189465632","title":"Medpace 第二季度营收达7.073亿美元，超出市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1189465632","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189465632?lang=zh_cn&edition=full","pubTime":"2026-07-23 04:32","pubTimestamp":1784752322,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc. 近日公布了其第二季度财务业绩。数据显示，公司该季度营收达到7.073亿美元，显著超越了此前IBES调查分析师普遍预期的6.876亿美元。在盈利能力方面，Medpace第二季度实现净利润1.214亿美元，展现出强劲的盈利增长势头。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","MEDP","LU2065171311.SGD","LU2065170008.USD","LU2065169927.USD","BK4121","LU2065171402.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153464851","title":"财报前瞻｜Medpace Holdings Inc.本季度营收预计增27.83%，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1153464851","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153464851?lang=zh_cn&edition=full","pubTime":"2026-07-15 09:24","pubTimestamp":1784078648,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc.将于2026年07月22日美股盘后发布财报，市场关注新增订单与取消率的边际变化、领导层交接对交付节奏的影响及盈利韧性。上季度Medpace Holdings Inc.实现营收7.07亿美元，同比增长26.50%，毛利率71.94%，归属于母公司股东的净利润1.24亿美元，净利率17.53%，调整后每股收益4.28美元，同比增长16.62%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Medpace Holdings Inc.本季度营收预计增27.83%，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146409581","title":"异动解读｜Medpace Holdings盘中上涨7.2%，报507.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1146409581","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146409581?lang=zh_cn&edition=full","pubTime":"2026-06-25 00:13","pubTimestamp":1782317604,"startTime":"0","endTime":"0","summary":"6月24日，Medpace Holdings盘中上涨7.2%，报507.55美元/股，成交额9007.42万美元。Medpace Holdings所在的生命科学工具和服务行业中，个股普遍走强，其中ICON plc涨12.56%，Illumina涨6.33%，丹纳赫涨4.91%，梅特勒-托利多涨4.63%，赛默飞世尔涨4.1%。Medpace Holdings是全球领先的临床合同研究组织之一，专注于为生物技术、制药和医疗器械行业提供以科学为导向的外包临床开发服务，覆盖I至IV期全流程临床开发，在肿瘤学、代谢疾病、心脏病学等治疗领域具有突出优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148487634","title":"异动解读 | 总裁杰西·盖格辞职引发市场担忧，Medpace Holdings盘中大跌26.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148487634","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148487634?lang=zh_cn&edition=full","pubTime":"2026-04-23 21:36","pubTimestamp":1776951406,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc.（股票代码：MEDP）今日盘中股价大幅下跌26.22%，引发了市场的广泛关注。消息面上，公司总裁杰西·盖格已于近日正式通知董事会其辞去总裁职务的意向。作为全球领先的临床研究组织，这一核心高管的突然离任引发了市场对公司短期运营稳定性及未来战略连续性的担忧，显著冲击了投资者情绪，成为股价剧烈波动的主要驱动因素。公司表示将立即启动继任者遴选程序，以确保领导层平稳过渡，但市场短期内仍对管理层真空期的不确定性保持高度警惕。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122980686","title":"异动解读 | 总裁杰西·盖格辞职引发担忧，Medpace Holdings盘前大跌17.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=1122980686","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122980686?lang=zh_cn&edition=full","pubTime":"2026-04-23 19:19","pubTimestamp":1776943158,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc.（股票代码：MEDP）今日盘前股价大跌17.29%，引起了市场的广泛关注。消息面上，公司总裁杰西·盖格已于4月21日正式通知董事会其辞去总裁职务的意向。作为全球领先的临床研究组织，这一核心高管的突然离任引发了市场对公司短期运营稳定性及未来战略连续性的担忧，显著冲击了投资者情绪，成为股价剧烈波动的主要驱动因素。公司表示将立即启动继任者遴选程序，以确保领导层平稳过渡，但市场短期内仍对管理层真空期的不确定性保持高度警惕。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161015499","title":"异动解读 | 总裁杰西·盖格辞职引发担忧，Medpace Holdings夜盘大跌12.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=1161015499","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161015499?lang=zh_cn&edition=full","pubTime":"2026-04-23 08:04","pubTimestamp":1776902654,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc.（股票代码：MEDP）今日夜盘股价大跌12.58%，引起了市场的广泛关注。消息面上，公司宣布总裁杰西·盖格已正式通知董事会其辞去总裁职务的意向。这一重大人事变动标志着这家全球领先的临床研究组织即将迎来管理层调整，引发了市场对公司短期运营稳定性及未来战略连续性的担忧，投资者情绪受到显著冲击。公司表示将立即启动继任者遴选程序，以确保领导层平稳过渡。此次高层变动是导致夜盘股价剧烈波动的主要原因。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125049956","title":"异动解读 | 总裁杰西·盖格辞职，Medpace Holdings盘后大跌19.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=1125049956","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125049956?lang=zh_cn&edition=full","pubTime":"2026-04-23 04:46","pubTimestamp":1776890800,"startTime":"0","endTime":"0","summary":"临床研究组织Medpace Holdings Inc.今日盘后股价出现大幅下挫，跌幅达19.44%，引起了市场的广泛关注。消息面上，公司于近期宣布，总裁杰西·盖格已正式通知董事会其辞去总裁职务的意向。这一重大人事变动标志着公司管理层即将迎来调整，可能引发了市场对公司短期稳定性和未来战略连续性的担忧。公司表示，将立即启动继任者的遴选程序，以确保领导层的平稳过渡。此次高层变动对投资者情绪造成了显著影响，直接反映在盘后交易中股价的剧烈波动上。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117838084","title":"Medpace Holdings Inc.总裁杰西·盖格将于2026年4月21日通知公司其辞职意向","url":"https://stock-news.laohu8.com/highlight/detail?id=1117838084","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117838084?lang=zh_cn&edition=full","pubTime":"2026-04-23 04:45","pubTimestamp":1776890717,"startTime":"0","endTime":"0","summary":"2026年4月21日，Medpace Holdings Inc.宣布，公司总裁杰西·盖格已正式通知董事会其辞去总裁职务的意向。\n这一重大人事变动标志着这家全球领先的临床研究组织即将迎来管理层调整。公司表示将立即启动继任者遴选程序，以确保领导层平稳过渡。\n","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065170008.USD","MEDP","LU2065171402.SGD","LU2065169927.USD","BK4121","LU2065171311.SGD","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175230634","title":"财报前瞻 ｜Medpace Holdings Inc.本季度营收预计增32.55%，机构观点偏乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1175230634","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175230634?lang=zh_cn&edition=full","pubTime":"2026-04-15 09:10","pubTimestamp":1776215406,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc.将于2026年04月22日盘后发布财报，市场关注收入与利润的延续性增长及订单动能对全年指引的影响。市场一致预期本季度公司营收为6.98亿美元，同比增长32.55%；调整后每股收益为3.88美元，同比增长27.08%；息税前利润为1.33亿美元，同比增长20.40%。目前主流一致预估未给出本季度毛利率与净利润或净利率的量化预测，官方层面也未披露明确区间。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻 ｜Medpace Holdings Inc.本季度营收预计增32.55%，机构观点偏乐观","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514063909","title":"盟科药业：全资子公司盟科美国对Medpace提起诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=2514063909","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514063909?lang=zh_cn&edition=full","pubTime":"2025-02-25 16:52","pubTimestamp":1740473555,"startTime":"0","endTime":"0","summary":"每经AI快讯，2月25日，盟科药业公告称，公司全资子公司盟科美国于2025年2月24日收到美国俄亥俄州南区联邦地区法院西部分院起诉立案确认通知，盟科美国诉Medpace合同纠纷一案已完成起诉立案。盟科美国请求判令Medpace赔偿因违反合同义务和不当行为导致的损失、成本和费用以及利息，具体金额将在庭审中证明。目前案件尚未开庭审理，最终实际影响需以后续法院判决或执行结果为准。公司已完成注射用MRX-4的中国III期临床试验，本次诉讼事宜不涉及对该试验的影响。文章来源：每日经济新闻原标题：盟科药业：全资子公司盟科美国对Medpace提起诉讼","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225170609a2532c26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225170609a2532c26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU2065171402.SGD","BK4121","LU2065171311.SGD","BK4585","LU2065169927.USD","MEDP","LU2065170008.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511692167","title":"Medpace Holdings, Inc.2024财年实现净利润4.04亿美元，同比增加42.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511692167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511692167?lang=zh_cn&edition=full","pubTime":"2025-02-15 00:00","pubTimestamp":1739548835,"startTime":"0","endTime":"0","summary":"2月15日，Medpace Holdings, Inc.公布财报，公告显示公司2024财年净利润为4.04亿美元，同比增加42.76%；其中营业收入为21.09亿美元，同比增加11.82%，每股基本收益为13.06美元。从资产负债表来看，Medpace Holdings, Inc.总负债12.75亿美元，其中短期债务23.29百万美元，资产负债比为1.65，流动比率为0.94。机构评级：截至2025年2月15日，当前有8家机构对Medpace Holdings, Inc.目标价做出预测，其中目标均价为354.38美元，其中最低目标价为300.00美元，最高目标价为400.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215000055a246151e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215000055a246151e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510312861","title":"净利润飙升50%！CRO龙头Q4业绩公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2510312861","media":"生物药大时代","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510312861?lang=zh_cn&edition=full","pubTime":"2025-02-12 11:53","pubTimestamp":1739332418,"startTime":"0","endTime":"0","summary":"近日，海外CRO龙头Medpace公布2024年业绩：截至 2024 年 12 月 31 日止，全年收入21.09亿美元，同比增长11.8% 。其中Q4营收5.366 亿美元，同比增长7.7%，积压订单转化率为 18.3%。值得注意的是，Q4净利润激增50％到1.17 亿美元；全年净利润大增43%至4.04亿美元。截至 2025 年 2 月 12 日，其总市值达 109.9 亿美元。自上市以来，该公司表现较为亮眼，上市 8 年间股价大涨超 1600%，并在 2024 年 7 月 17 日创下 459.77 美元的历史新高水平 。目前，全球约有一千多家 CRO 机构，大型企业占据主导地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212140209abcbd90e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212140209abcbd90e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510803443","title":"Medpace Holdings, Inc.盘中异动 急速跳水6.35%报332.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510803443","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510803443?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:31","pubTimestamp":1739284268,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时31分，Medpace Holdings, Inc.股票出现异动，股价大幅下挫6.35%。截至发稿，该股报332.01美元/股，成交量2.1873万股，换手率0.07%，振幅0.62%。Medpace Holdings, Inc.股票所在的生命科学行业中，整体跌幅为0.46%。Medpace Holdings, Inc.公司简介：Medpace 是一家成立超过30年的晚期合同研究组织，为中小型生物技术、制药和医疗器械公司提供全方位的药物开发和临床试验服务。全球私募股权公司Cinven于2014年以9.15亿美元收购了Medpace，并于2018年退出了投资。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223108961f476f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223108961f476f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065169927.USD","LU2065171311.SGD","LU2065170008.USD","MEDP","LU2065171402.SGD","BK4121","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.medpace.com","stockEarnings":[{"period":"1week","weight":-0.0064},{"period":"1month","weight":-0.0158},{"period":"3month","weight":0.2572},{"period":"6month","weight":0.3044},{"period":"1year","weight":0.1807},{"period":"ytd","weight":0.0461}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Medpace Holdings, Inc.于2014年2月18日在美国特拉华州注册成立，是全球领先的临床合同研究组织（CRO）之一，专注于为生物技术、制药和医疗器械行业提供以科学为导向的外包临床开发服务。公司提供覆盖I至IV期的全流程临床开发服务，在肿瘤学、代谢疾病、心脏病学、抗病毒与抗感染（AVAI）以及中枢神经系统（CNS）等治疗领域具有突出优势。Medpace业务遍及所有主要治疗领域，凭借其规范化的运营模式，致力于为中小型生物制药公司提供及时、高质量且具成本效益的临床试验服务，从而成为其优先合作对象。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.006402},{"month":2,"riseRate":0.3,"avgChangeRate":-0.035449},{"month":3,"riseRate":0.7,"avgChangeRate":0.006916},{"month":4,"riseRate":0.6,"avgChangeRate":-0.007726},{"month":5,"riseRate":0.5,"avgChangeRate":0.025051},{"month":6,"riseRate":1,"avgChangeRate":0.085381},{"month":7,"riseRate":0.7,"avgChangeRate":0.142259},{"month":8,"riseRate":0.7,"avgChangeRate":0.032474},{"month":9,"riseRate":0.545455,"avgChangeRate":-0.005034},{"month":10,"riseRate":0.5,"avgChangeRate":0.057543},{"month":11,"riseRate":0.7,"avgChangeRate":0.057867},{"month":12,"riseRate":0.7,"avgChangeRate":0.025222}],"exchange":"NASDAQ","name":"Medpace Holdings Inc.","nameEN":"Medpace"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Medpace Holdings Inc.(MEDP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Medpace Holdings Inc.(MEDP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Medpace Holdings Inc.,MEDP,Medpace Holdings Inc.股票,Medpace Holdings Inc.股票老虎,Medpace Holdings Inc.股票老虎国际,Medpace Holdings Inc.行情,Medpace Holdings Inc.股票行情,Medpace Holdings Inc.股价,Medpace Holdings Inc.股市,Medpace Holdings Inc.股票价格,Medpace Holdings Inc.股票交易,Medpace Holdings Inc.股票购买,Medpace Holdings Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Medpace Holdings Inc.(MEDP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Medpace Holdings Inc.(MEDP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}